HRS Guidelines Bundle (free trial)

Evaluation and Management of Arrhythmic Risk in Neuromuscular Disorders

Heart Rhythm Society GUIDELINES Apps brought to you free pf charge, courtesy of Guideline Central. Enjoy!

Issue link: https://eguideline.guidelinecentral.com/i/1499527

Contents of this Issue

Navigation

Page 46 of 49

47 Management strategies Key points • Referral for evaluation by pulmonary medicine showed restrictive pulmonary function testing consistent with severe respiratory muscle involvement. • Coordinated care of patient was conducted with discussion with neurolog y, pulmonary medicine, and cardiac EP regarding neuromuscular prognosis. Consensus that the likelihood of poor cardiac or respiratory outcome over the next 2–4 years was high. • Conference with the patient and husband held to elicit the medical care goals. The discussion included the high risk for both cardiac and pulmonary complications of DM1. The risk of sudden cardiac death was discussed based on the severe cardiac conduction disease on the ECG. Included in the discussion was a review of the potential benefit of a primary prevention pacemaker or ICD. An option discussed included ongoing follow-up without device implantation. • The patient and family elected to proceed with a dual-chamber pacemaker implantation. • The procedure was done with anesthesia support and required intubation. Pacemaker was implanted without complications. However, there was failure to wean off the ventilator post-procedure. The patient remained in the intensive care unit for 2 weeks due to neuromuscular-related respiratory failure. • Despite marginal respiratory status, the patient was able to wean off the ventilator with nocturnal bi-level positive airway pressure support, and the patient was discharged 3 weeks post-implantation. • At 6-month follow-up after pacemaker implantation, complete heart block was observed with pacing suppression. No escape rhythm was observed with pacing at 30 bpm. • The patient had progressive respiratory insufficiency and succumbed to pneumonia 2 years after pacemaker implantation. • The husband sent a thank you note to the care team for providing his wife with additional time to spend with him and their son who had congenital DM1. • Poor functional status portends the high risk for poor mid- to long-term outcomes. • Empiric pacemaker implantation without further testing is reasonable given the ECG with severe conduction disease. • Clinical benefit of empiric ICD placement remains uncertain and would be potentially less advantageous as long-term outcome in the patient is poor. • Eliciting the overall goals of care and preferences led to the patient's decision to go ahead with pacemaker implantation. • Coordinated care between neurolog y, pulmonary medicine, cardiac EP, and anesthesiolog y led to a procedure with the anticipated issues but overall favorable outcome.

Articles in this issue

Archives of this issue

view archives of HRS Guidelines Bundle (free trial) - Evaluation and Management of Arrhythmic Risk in Neuromuscular Disorders